Engineering Myeloid Cells for Cancer – Ex Vivo & In Vivo Approaches
Time: 12:30 pm
day: Conference Day Two
Details:
- Exploring CAR-M for solid tumor immunotherapy
- Reviewing the clinical program overview of Anti-HER2 CAR-M ex vivo cell therapy
- Utilizing direct in vivo CAR reprogramming using mRNA
